menu
    • menu

    Company profile for Vernalis

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    With Virupaksha, you get a quality product with on-time delivery.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-11-24

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    ChemExpress delivers end-to-end CRO & CDMO solutions for small molecules, biologics & new modalities with ICH-grade quality.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    We develop and apply fragment and structure-based methods to solve problems in drug discovery, and have generated cell active lead compounds and development candidates against targets in oncology, neurodegeneration, anti-infectives and inflammation. Our established group of experienced scientists is based at our fully-equipped research laboratories on Granta Park, Cambridge UK. We integrate fragment-based approaches, struct...
    We develop and apply fragment and structure-based methods to solve problems in drug discovery, and have generated cell active lead compounds and development candidates against targets in oncology, neurodegeneration, anti-infectives and inflammation. Our established group of experienced scientists is based at our fully-equipped research laboratories on Granta Park, Cambridge UK. We integrate fragment-based approaches, structural biology, biophysics, assay technology and molecular modelling with extensive medicinal chemistry expertise to enable drug discovery on both established and novel targets. We have the experience and capabilities.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Vernalisunitedkingdom_new Flag
    Country
    Country
    United Kingdom
    Address
    Address
    Granta Park Great Abington Cambridge CB21 6GB
    Telephone
    Telephone
    +44 (0)1223 895555
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.vernalis.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/vernalis/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Hox and Vernalis announce a drug discovery collaboration in oncology
    Hox and Vernalis announce a drug discovery collaboration in oncology

    20 Feb 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/hox-therapeutics-and-vernalis-announce-a-drug-discovery-collaboration-in-oncology-302065769.html

    PR NEWSWIRE
    20 Feb 2024
    Share Share
    Pierre Fabre and Vernalis announce a drug discovery collaboration in oncology
    Pierre Fabre and Vernalis announce a drug discovery collaboration in oncology

    25 Sep 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/pierre-fabre-laboratories-and-vernalis-announce-a-drug-discovery-collaboration-in-oncology-301936165.html

    PR NEWSWIRE
    25 Sep 2023
    Share Share
    HitGen and Unison Medicines join hands to develop anti-infectives
    HitGen and Unison Medicines join hands to develop anti-infectives

    06 Sep 2022

    // BIOSPECTRUMASIA

    https://www.biospectrumasia.com/news/25/20983/hitgen-and-unison-medicines-join-hands-to-develop-anti-infectives.html

    BIOSPECTRUMASIA
    06 Sep 2022
    Share Share
    Vernalis Research, a fully owned subsidiary of HitGen Inc., and Unison Medicines
    Vernalis Research, a fully owned subsidiary of HitGen Inc., and Unison Medicines

    05 Sep 2022

    // PHARMABIZ

    http://www.pharmabiz.com/NewsDetails.aspx?aid=153041&sid=2

    PHARMABIZ
    05 Sep 2022
    Share Share
    Gilead bought his last biotech. Now, Helin has a new startup
    Gilead bought his last biotech. Now, Helin has a new startup

    01 Nov 2021

    // Nick Paul Taylor FIERCEBIOTECH

    https://www.fiercebiotech.com/biotech/gilead-bought-his-last-biotech-now-helin-back-another-cancer-startup

    Nick Paul Taylor FIERCEBIOTECH
    01 Nov 2021
    Share Share
    Vernalis and Hannibal Innovation Announce the Creation of Dania Therapeutics ApS
    Vernalis and Hannibal Innovation Announce the Creation of Dania Therapeutics ApS

    31 Oct 2021

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20211031005007/en

    BUSINESSWIRE
    31 Oct 2021
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search